Loading…

MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1

MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the r...

Full description

Saved in:
Bibliographic Details
Published in:Cancer cell international 2014-07, Vol.14 (1), p.70-70, Article 70
Main Authors: Chen, Xiao-Nan, Wang, Ke-Feng, Xu, Zhen-Qun, Li, Shi-Jie, Liu, Qiang, Fu, Dong-Hui, Wang, Xia, Wu, Bin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623
cites cdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623
container_end_page 70
container_issue 1
container_start_page 70
container_title Cancer cell international
container_volume 14
creator Chen, Xiao-Nan
Wang, Ke-Feng
Xu, Zhen-Qun
Li, Shi-Jie
Liu, Qiang
Fu, Dong-Hui
Wang, Xia
Wu, Bin
description MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown. The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively. The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P 
doi_str_mv 10.1186/s12935-014-0070-3
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4238049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3397204091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</originalsourceid><addsrcrecordid>eNp1kstq3TAURUVpaR7tB3QSDJ10ouQcy3pNCnknkFAo7bRCtuUbpb6WI8kN-fv45iYhKe3oCM7SZrMkQj4h7CIqsZew1IxTwIoCSKDsDdnESnJaKiHfvjhvkK2UrgFQKgHvyUbJK6y45pvk16X_TpGxuohuMfU2u1TUvW1bF4vGDs1quL4vxhh637losw9DYYe2sGMYc0h-5u-KbOPCZT8sioOmp7cPwP7vjB_Iu872yX18nNvk58nxj8MzevHt9Pxw_4LWXOlMnQULWoNGzZhtOugUh7pWolNaIGLJuVPcCiVl10gNiLVjUrUCWtlpUbJt8nWdO0710rWNG3K0vRmjX9p4Z4L15vVm8FdmEf6YqmQKKj0HHK0Dah_-E_B604SlWfs3s3-z8m_YHPPlsUcMN5NL2Sx9Wgm0gwtTMiiY5JxpJWf081_odZjiMFsyyHmJnGElZgrXVBNDStF1z5UQzOoT_LPEzksZzzeeXp3dA9nIrJI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552153146</pqid></control><display><type>article</type><title>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</title><source>PubMed Central Free</source><source>Publicly Available Content (ProQuest)</source><creator>Chen, Xiao-Nan ; Wang, Ke-Feng ; Xu, Zhen-Qun ; Li, Shi-Jie ; Liu, Qiang ; Fu, Dong-Hui ; Wang, Xia ; Wu, Bin</creator><creatorcontrib>Chen, Xiao-Nan ; Wang, Ke-Feng ; Xu, Zhen-Qun ; Li, Shi-Jie ; Liu, Qiang ; Fu, Dong-Hui ; Wang, Xia ; Wu, Bin</creatorcontrib><description><![CDATA[MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown. The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively. The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both). MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.]]></description><identifier>ISSN: 1475-2867</identifier><identifier>EISSN: 1475-2867</identifier><identifier>DOI: 10.1186/s12935-014-0070-3</identifier><identifier>PMID: 25414595</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Apoptosis ; Bladder cancer ; Cell growth ; Flow cytometry ; Gene expression ; Kinases ; Medical research ; MicroRNAs ; Molecular weight ; Primary Research ; Proteins ; Rodents ; Software ; Statistical analysis ; Studies ; Tumors ; Variance analysis</subject><ispartof>Cancer cell international, 2014-07, Vol.14 (1), p.70-70, Article 70</ispartof><rights>2014 Wu et al.; licensee Springer This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Copyright © 2014 Wu et al.; licensee Springer 2014 Wu et al.; licensee Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</citedby><cites>FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238049/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1552153146?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25414595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Xiao-Nan</creatorcontrib><creatorcontrib>Wang, Ke-Feng</creatorcontrib><creatorcontrib>Xu, Zhen-Qun</creatorcontrib><creatorcontrib>Li, Shi-Jie</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><creatorcontrib>Fu, Dong-Hui</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><creatorcontrib>Wu, Bin</creatorcontrib><title>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</title><title>Cancer cell international</title><addtitle>Cancer Cell Int</addtitle><description><![CDATA[MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown. The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively. The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both). MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.]]></description><subject>Apoptosis</subject><subject>Bladder cancer</subject><subject>Cell growth</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Kinases</subject><subject>Medical research</subject><subject>MicroRNAs</subject><subject>Molecular weight</subject><subject>Primary Research</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Studies</subject><subject>Tumors</subject><subject>Variance analysis</subject><issn>1475-2867</issn><issn>1475-2867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kstq3TAURUVpaR7tB3QSDJ10ouQcy3pNCnknkFAo7bRCtuUbpb6WI8kN-fv45iYhKe3oCM7SZrMkQj4h7CIqsZew1IxTwIoCSKDsDdnESnJaKiHfvjhvkK2UrgFQKgHvyUbJK6y45pvk16X_TpGxuohuMfU2u1TUvW1bF4vGDs1quL4vxhh637losw9DYYe2sGMYc0h-5u-KbOPCZT8sioOmp7cPwP7vjB_Iu872yX18nNvk58nxj8MzevHt9Pxw_4LWXOlMnQULWoNGzZhtOugUh7pWolNaIGLJuVPcCiVl10gNiLVjUrUCWtlpUbJt8nWdO0710rWNG3K0vRmjX9p4Z4L15vVm8FdmEf6YqmQKKj0HHK0Dah_-E_B604SlWfs3s3-z8m_YHPPlsUcMN5NL2Sx9Wgm0gwtTMiiY5JxpJWf081_odZjiMFsyyHmJnGElZgrXVBNDStF1z5UQzOoT_LPEzksZzzeeXp3dA9nIrJI</recordid><startdate>20140719</startdate><enddate>20140719</enddate><creator>Chen, Xiao-Nan</creator><creator>Wang, Ke-Feng</creator><creator>Xu, Zhen-Qun</creator><creator>Li, Shi-Jie</creator><creator>Liu, Qiang</creator><creator>Fu, Dong-Hui</creator><creator>Wang, Xia</creator><creator>Wu, Bin</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140719</creationdate><title>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</title><author>Chen, Xiao-Nan ; Wang, Ke-Feng ; Xu, Zhen-Qun ; Li, Shi-Jie ; Liu, Qiang ; Fu, Dong-Hui ; Wang, Xia ; Wu, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Apoptosis</topic><topic>Bladder cancer</topic><topic>Cell growth</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Kinases</topic><topic>Medical research</topic><topic>MicroRNAs</topic><topic>Molecular weight</topic><topic>Primary Research</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Studies</topic><topic>Tumors</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Xiao-Nan</creatorcontrib><creatorcontrib>Wang, Ke-Feng</creatorcontrib><creatorcontrib>Xu, Zhen-Qun</creatorcontrib><creatorcontrib>Li, Shi-Jie</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><creatorcontrib>Fu, Dong-Hui</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><creatorcontrib>Wu, Bin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer cell international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Xiao-Nan</au><au>Wang, Ke-Feng</au><au>Xu, Zhen-Qun</au><au>Li, Shi-Jie</au><au>Liu, Qiang</au><au>Fu, Dong-Hui</au><au>Wang, Xia</au><au>Wu, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</atitle><jtitle>Cancer cell international</jtitle><addtitle>Cancer Cell Int</addtitle><date>2014-07-19</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>70</spage><epage>70</epage><pages>70-70</pages><artnum>70</artnum><issn>1475-2867</issn><eissn>1475-2867</eissn><abstract><![CDATA[MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown. The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively. The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both). MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.]]></abstract><cop>England</cop><pub>BioMed Central</pub><pmid>25414595</pmid><doi>10.1186/s12935-014-0070-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1475-2867
ispartof Cancer cell international, 2014-07, Vol.14 (1), p.70-70, Article 70
issn 1475-2867
1475-2867
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4238049
source PubMed Central Free; Publicly Available Content (ProQuest)
subjects Apoptosis
Bladder cancer
Cell growth
Flow cytometry
Gene expression
Kinases
Medical research
MicroRNAs
Molecular weight
Primary Research
Proteins
Rodents
Software
Statistical analysis
Studies
Tumors
Variance analysis
title MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A27%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MiR-133b%20regulates%20bladder%20cancer%20cell%20proliferation%20and%20apoptosis%20by%20targeting%20Bcl-w%20and%20Akt1&rft.jtitle=Cancer%20cell%20international&rft.au=Chen,%20Xiao-Nan&rft.date=2014-07-19&rft.volume=14&rft.issue=1&rft.spage=70&rft.epage=70&rft.pages=70-70&rft.artnum=70&rft.issn=1475-2867&rft.eissn=1475-2867&rft_id=info:doi/10.1186/s12935-014-0070-3&rft_dat=%3Cproquest_pubme%3E3397204091%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552153146&rft_id=info:pmid/25414595&rfr_iscdi=true